Toronto Dominion Bank Has $3.30 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Toronto Dominion Bank boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 11.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 99,358 shares of the medical instruments supplier’s stock after purchasing an additional 9,824 shares during the quarter. Toronto Dominion Bank’s holdings in DENTSPLY SIRONA were worth $3,298,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Advisors Asset Management Inc. raised its position in DENTSPLY SIRONA by 99.3% in the 1st quarter. Advisors Asset Management Inc. now owns 14,548 shares of the medical instruments supplier’s stock worth $483,000 after purchasing an additional 7,248 shares during the last quarter. Boulder Hill Capital Management LP acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at $249,000. UniSuper Management Pty Ltd increased its position in DENTSPLY SIRONA by 1,153.6% in the first quarter. UniSuper Management Pty Ltd now owns 26,126 shares of the medical instruments supplier’s stock worth $867,000 after purchasing an additional 24,042 shares during the period. Seven Eight Capital LP bought a new stake in DENTSPLY SIRONA during the 1st quarter worth about $1,409,000. Finally, Champlain Investment Partners LLC boosted its stake in shares of DENTSPLY SIRONA by 11.3% in the 1st quarter. Champlain Investment Partners LLC now owns 4,290,737 shares of the medical instruments supplier’s stock valued at $142,410,000 after purchasing an additional 434,155 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. The Goldman Sachs Group cut their price objective on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Evercore ISI reduced their target price on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $33.67.

Read Our Latest Research Report on XRAY

DENTSPLY SIRONA Stock Performance

XRAY opened at $26.41 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The business’s 50-day moving average price is $26.32 and its two-hundred day moving average price is $30.43. DENTSPLY SIRONA Inc. has a 1 year low of $23.94 and a 1 year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting the consensus estimate of $0.42. The firm had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.39 EPS. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.64 annualized dividend and a yield of 2.42%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier bought 3,577 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The shares were acquired at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the acquisition, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.